Mexican Registry of Dyslipidemia in Patients at High Risk and Very High Risk of Atherosclerotic Cardiovascular

UnknownOBSERVATIONAL
Enrollment

13,166

Participants

Timeline

Start Date

August 4, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Secondary PreventionCardiovascular Disease With Mention of ArteriosclerosisDyslipidemias
Interventions
OTHER

application

"Through the application, determine if the patient is out of LDL-C goals for referral and treatment review.~Show the usefulness of the application in achieving dyslipidemia treatment goals in patients with high and extremely high cardiovascular risk"

Trial Locations (1)

Unknown

RECRUITING

Umae Cmn T1, León

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT05542719 - Mexican Registry of Dyslipidemia in Patients at High Risk and Very High Risk of Atherosclerotic Cardiovascular | Biotech Hunter | Biotech Hunter